Cargando…
Lanreotide in the prevention and management of high-output ileostomy after colorectal cancer surgery
Objective: Patients with stage III and high-risk stage II colorectal cancer (CRC) are advised to initiate adjuvant treatment as soon as feasible and certainly before 8 to 12 weeks after resection of the tumor. A protective ileostomy is often constructed during surgery to protect a primary anastomosi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990955/ https://www.ncbi.nlm.nih.gov/pubmed/29888099 http://dx.doi.org/10.1080/21556660.2018.1467916 |